Furthermore, we demonstrated that DUXAP9‐206 induced NSCLC cell proliferation and metastasis by directly interacting with Cbl‐b, an E3 ubiquitin ligase and reducing the degradation of EGFR, thus activating the EGFR signaling pathway. This evidence concerns the gene DUXAP9 and non-small cell lung carcinoma.